Zofran (ondansetron) MDL Judge Denies GlaxoSmithKline’s Request for Dismissal as Premature
In the latest development of the Zofran (ondansetron) multi-district litigation, GlaxoSmithKline’s request for dismissal of all claims were denied by Judge F. Dennis Saylor IV, the Massachusetts district judge presiding over the litigation. About 200 cases with similar claims were consolidated into the multidistrict litigation, or “MDL,” for the purpose of streamlining pre-trial proceedings and …. Read More
